Timothy Anderson, an analyst at Prudential Equity Group, wrote in a note yesterday that liver toxicities seen with Prexige could be a commercial "deal killer" but that the results may help Merck.

FORBES: Study Revives Debate On Arthritis Drugs

Within 20-30 years, I don't think it's reasonable to expect a cure for cancer, but it is reasonable to expect that we can manage the disease much, much better and keep people symptom-free without burdening them with the horrible toxicities they endure nowadays with chemotherapy.

FORBES: Magazine Article